Insilico Medicine

Insilico Medicine is a biotechnology company that leverages artificial intelligence to revolutionize drug discovery and development. The company focuses on using advanced machine learning techniques to accelerate the process of identifying new drug targets, designing novel molecules, and optimizing clinical trials. 

Healx

Healx is a biotechnology company focused on accelerating the discovery and development of treatments for rare diseases. The company utilizes artificial intelligence and machine learning to identify potential drug candidates and repurpose existing drugs for faster and more cost-effective solutions for patients with unmet medical needs. 

Absci

Absci is a biotechnology company that uses artificial intelligence to revolutionize the process of creating new biologic drugs. They specialize in designing antibodies from scratch using computer algorithms, bypassing traditional methods that rely on existing antibody libraries. Absci’s platform combines AI-driven design with rapid experimental validation to significantly reduce the time and cost typically associated with bringing new drug candidates to clinical trials.

Genesis Therapeutics

Genesis Therapeutics is a biotechnology company that focuses on using artificial intelligence to accelerate drug discovery and development. The company employs a team of drug researchers, deep learning experts, and software engineers to create advanced molecular AI platforms. 

Exscientia

Exscientia is a pioneering pharmaceutical company that leverages artificial intelligence to revolutionize drug discovery and development. The company focuses on creating precision-designed drugs using advanced AI algorithms and machine learning techniques.

Evaxion Biotech

Evaxion Biotech is a biotechnology company that specializes in developing vaccines using artificial intelligence. Their proprietary AI platform is designed to identify potential vaccine targets for both cancer and infectious diseases.

Envisagenics

Envisagenics is an AI-driven biotechnology company that specializes in RNA splicing research and therapeutic development. They use their proprietary platform, which combines artificial intelligence and machine learning, to analyze RNA sequencing data and identify novel RNA splicing variants associated with diseases.

AcuraStem

AcuraStem is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases, including ALS and frontotemporal dementia. Utilizing its proprietary iNeuroRx® platform, AcuraStem creates patient-derived disease models that accurately reflect the complexities of these conditions. By integrating advanced AI techniques, the company aims to identify effective therapeutics tailored to individual patient needs, enhancing the potential for successful treatment outcomes in neurodegeneration.

Verge Genomics

Verge Genomics is a biotechnology company that uses artificial intelligence and human genomic data to discover and develop new drugs for complex diseases. They have a proprietary platform called that analyzes patient tissue data to identify potential drug targets.

Tempus

Tempus is a technology company that applies artificial intelligence to healthcare data. They analyze clinical and molecular information, including DNA, RNA, and pathology images, to advance precision medicine.